REG - Substrate AI-Class B - Strategy update and forecasts 2024

Substrate Artificial Inteligence SAAnnouncement

11/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240411:nRSK1126Ka&default-theme=true

RNS Number : 1126K  Substrate Artificial Intel - B    11 April 2024

11 April 2024

 

 

SUBSTRATE ARTIFICIAL INTELIGENCE SOCIEDAD ANONIMA

("Substrate AI" or the "Company")

STRATEGY UPDATE AND FORECASTS 2024

Substrate AI (AQUIS: SAI/SAI.B) announces that it will hold an investor day on
11 April 2024, an event where the Company will share with shareholders and
potential investors the application of its technology, business strategies and
forecasts for the Company and its subsidiaries. The event will take place at
6:30 pm at The Brewery, EC1Y 4SD.

As part of its business strategy, by 2028 the Company intends to bring three
of its subsidiaries to public markets, Subgen AI Ltd, Cuarta dimensión medica
SL and Fleebe AI SL.

Subgen AI Ltd is a company that develops artificial intelligence ("AI")
technology in the field of generative AI and reinforced learning for companies
and institutions. This company applies LLM models with a suite of solutions
for complex tasks.

Cuarta Dimensión Médica SL is a company that applies AI in the health
industry, specifically in diagnostic imaging.

Fleebe AI SL is a company that applies AI in the human resources sector,
focusing on talent acquisition and retention.

Furthermore, the Company announces that the Company's Board of Directors, at
its meeting held on 8 April 2024, approved the following projections for the
2024 financial year:

 

 

 

Revenue

An increase in consolidated turnover is projected based exclusively on organic
growth.

Expense

Personnel expenditure increases proportionately much less than revenues,
increasing the revenue-per-employee ratio.

On the other hand, the rest of operating expenses are reduced compared to 2023
due to the lower investments required.

EBITDA

In terms of EBITDA, it is positive for the first time since the IPO on the BME
Growth Market.

This announcement contains information which, prior to its disclosure, was
inside information as stipulated under Regulation 11 of the Market Abuse
(Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication
of this announcement via a Regulatory Information Service, this inside
information is now considered to be in the public domain.

 

DISCLAIMER

 

This announcement may contain forward-looking statements. The forward-looking
statements include, but are not limited to, statements regarding the
Company's, or the Directors' expectations, hopes, beliefs, intentions or
strategies regarding the future. In addition, any statement that refers to
projections, forecasts or other characterisations of future events or
circumstances, including any underlying assumptions, is a forward-looking
statement. The words "anticipate", "believe", "continue", "could", "estimate",
"expect", "intend", "may", "might", "plan", "possible", "potential",
"predict", "project", "seek", "should", "would" and similar expressions, or in
each case their negatives, may identify forward-looking statements, but the
absence of these words does not mean that a statement is not forward-looking.

 

Forward-looking statements include all matters that are not historical facts.
Forward-looking statements are based on the current expectations and
assumptions regarding the Company, the business, the economy and other future
conditions. Because forward-looking statements relate to the future, by their
nature, they are subject to inherent uncertainties, risks and changes in
circumstances that are difficult to predict. Forward-looking statements are
not guarantees of future performance and the Company's actual financial
condition, actual results of operations and financial performance, and the
development of the industries in which it operates or will operate, may differ
materially from those made in or suggested by the forward-looking statements
contained in this announcement. In addition, even if the Company's financial
condition, results of operations and the development of the industries in
which it operates or will operate, are consistent with the forward-looking
statements contained in this announcement, those results or developments may
not be indicative of financial condition, results of operations or
developments in subsequent periods. Important factors that could cause actual
results to differ materially from those in the forward-looking statements
include regional, national or global, political, economic, social, business,
technological, competitive, market and regulatory conditions.

 

Any forward-looking statement contained in this announcement applies only as
of the date of this announcement and is expressly qualified in its entirety by
these cautionary statements. Factors or events that could cause the Company's
actual results to differ may emerge from time to time, and it is not possible
for the Company to predict all of them. The Company expressly disclaims any
obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained in this announcement to reflect any
change in its expectations or any change in events, conditions or
circumstances on which any forward-looking statement contained in this
announcement is based, unless required to do so by applicable law, the Aquis
Rules, the Disclosure Guidance and Transparency Rules of the FCA or the UK
Market Abuse Regulation.

 

The Directors of the Company accept responsibility for the contents of the
announcement.

For further information, please contact:

 Substrate AI
 Lorenzo Serratosa                 info@substrate.ai

 Chairman
 First Sentinel Corporate Finance

 Corporate Advisors
 Brian Stockbridge                 +44 (0) 7858 888 007

 

About Substrate AI: Substrate AI is an artificial intelligence company based
in Spain that creates, buys and scales companies around AI in diverse
sectors such as fintech, agritech, energy, human resources, or health. All of
them sell products and services built on the bio-inspired reinforced learning
technology developed and patented by Substrate AI.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXFFFFISSIILIS